Patents by Inventor Kirk Lane PAPPAN

Kirk Lane PAPPAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Biomarkers Related to Insulin Resistance Progression and Methods Using the Same
    Publication number: 20180203021
    Abstract: Biomarkers relating to insulin resistance and insulin resistance-related disorders are provided, as well as methods for using such biomarkers as biomarkers for insulin resistance, dysglycemia, type-2 diabetes, and cardiovascular disease. In addition, methods for monitoring the respective disorders or conditions of a subject are also provided. Also provided are suites of small molecule entities as biomarkers for insulin resistance, dysglycemia, type-2 diabetes, and cardiovascular disease.
    Type: Application
    Filed: January 16, 2018
    Publication date: July 19, 2018
    Inventors: Walter GALL, Jeffery Edmond Cobb, Kirk Lane Pappan
  • Biomarkers related to insulin resistance progression and methods using the same
    Patent number: 9910047
    Abstract: Biomarkers relating to insulin resistance and insulin resistance-related disorders are provided, as well as methods for using such biomarkers as biomarkers for insulin resistance, dysglycemia, type-2 diabetes, and cardiovascular disease. In addition, methods for monitoring the respective disorders or conditions of a subject are also provided. Also provided are suites of small molecule entities as biomarkers for insulin resistance, dysglycemia, type-2 diabetes, and cardiovascular disease.
    Type: Grant
    Filed: January 16, 2014
    Date of Patent: March 6, 2018
    Assignee: Metabolon, Inc.
    Inventors: Walter Gall, Jeffery Edmond Cobb, Kirk Lane Pappan
  • Biomarkers Related to Insulin Resistance Progression and Methods Using the Same
    Publication number: 20150362510
    Abstract: Biomarkers relating to insulin resistance and insulin resistance-related disorders are provided, as well as methods for using such biomarkers as biomarkers for insulin resistance, dysglycemia, type-2 diabetes, and cardiovascular disease. In addition, methods for monitoring the respective disorders or conditions of a subject are also provided. Also provided are suites of small molecule entities as biomarkers for insulin resistance, dysglycemia, type-2 diabetes, and cardiovascular disease.
    Type: Application
    Filed: January 16, 2014
    Publication date: December 17, 2015
    Inventors: Walter GALL, Jeffrey Edmond COBB, Kirk Lane PAPPAN